Apraclonidine ophthalmic and Dextranomer and Hyaluronate Derivatives (Deflux)
Determining the interaction of Apraclonidine ophthalmic and Dextranomer and Hyaluronate Derivatives (Deflux) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apraclonidine ophthalmic
Brand name: Iopidine
Synonyms: Apraclonidine
Generic Name: dextranomer / sodium hyaluronate
Brand name: Solesta
Synonyms: Dextranomer and sodium hyaluronate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apraclonidine ophthalmic-Dextranomer and Hyaluronate Derivatives (Solesta)
- Apraclonidine ophthalmic-Dextranomer and sodium hyaluronate
- Apraclonidine ophthalmic-Dextroamphetamine
- Apraclonidine ophthalmic-Dextroamphetamine and amphetamine
- Apraclonidine ophthalmic-Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Apraclonidine ophthalmic-Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
- Dextranomer and Hyaluronate Derivatives (Deflux)-Apremilast
- Dextranomer and Hyaluronate Derivatives (Deflux)-Aprepitant
- Dextranomer and Hyaluronate Derivatives (Deflux)-Aprepitant Capsules
- Dextranomer and Hyaluronate Derivatives (Deflux)-Aprepitant Injection
- Dextranomer and Hyaluronate Derivatives (Deflux)-Aprepitant Intravenous
- Dextranomer and Hyaluronate Derivatives (Deflux)-Aprepitant Oral Suspension